Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
23-valent pneumococcal vaccine
BIOLOGICAL
2 trials
Sponsors
Naval Health Research Center
, The First Affiliated Hospital of Guangzhou Medical University
Conditions
Acute Respiratory Disease
LUNG CANCER
Pneumonia
Phase 4
Effectiveness of the Pneumococcal Polysaccharide Vaccine in Military Recruits
Completed
NCT02079701
Naval Health Research Center
Acute Respiratory Disease, Pneumonia
Start: 2000-10-31
End: 2007-06-30
Updated: 2014-03-06
Unknown Phase
An Observational Study on the Impact of the 23-valent Pneumonia Vaccine on Lung Cancer Patients
Not yet recruiting
NCT07142057
The First Affiliated Hospital of Guangzhou Medical University
LUNG CANCER
Start: 2025-09-01
End: 2030-09-01
Target: 500
Updated: 2025-08-26
Related Papers
Lack of effectiveness of the 23-valent polysaccharide pneumococcal vaccine in reducing all-cause pneumonias among healthy young military recruits: a randomized, double-blind, placebo-controlled trial.
2015-01-08
10 citations